These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4740760)

  • 1. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans.
    Gerhards E; Lachnit U; Gaude R; Schillinger E
    Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose and insulin levels during treatment with a combined oral contraceptive agent.
    Larsson-Cohn U
    Acta Soc Med Ups; 1971; 76(5-6):223-7. PubMed ID: 5141078
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid metabolism in pregnancy. I. Changes in lipoprotein triglyceride and cholesterol in normal pregnancy and the effects of diabetes mellitus.
    Knopp RH; Warth MR; Carrol CJ
    J Reprod Med; 1973 Mar; 10(3):95-101. PubMed ID: 4348501
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum triglyceride in women with and without a predisposition to diabetes during short-term administration of a combined oral contraception.
    Nelson FH
    Acta Obstet Gynecol Scand; 1974; 53(1):13-9. PubMed ID: 4817622
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of oral contraceptives on glucose tolerance.
    Boshell BR; Roddam RF; McAdams GL; Fox OJ
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative studies on oral glucose tolerance and serum lipids under the influence of a new oral contraceptive (SH B 209 AB: 2 mg cyproterone acetate + 0.05 mg ethinyl estradiol), the combination D-norgestrel/ethinyl estradiol and in a control group (author's transl)].
    Schillinger E; Gerloff C; Wellershoff S; Wendt H; Lachnit-Fixson U
    Arzneimittelforschung; 1976; 26(12):2242-5. PubMed ID: 1037282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraception, mechanical contraception, and carbohydrate and lipid metabolism: a two-year study.
    Pribicevic V; Skrabalo Z; Lipovac V; Trenc S; Zadjelovic J; Rajkovic Z
    Int J Fertil; 1979; 24(2):114-9. PubMed ID: 40904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol).
    Andolsek KM; Burkman RT; Kafrissen ME; Olson W; Osterman J
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():122-5. PubMed ID: 8260970
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in laboratory tests after treatment with a new contraceptive agent].
    Cervantes LF; López Barcena J; Calderón Márquez JJ
    Ginecol Obstet Mex; 1978 Apr; 43(258):285-97. PubMed ID: 80349
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial with a combination of 150 mcg of d-norgestrel and 30 mcg of ethinylestradiol. Its metabolic effects].
    Moggia AV; Koremblit E; Beauquis A
    Obstet Ginecol Lat Am; 1976; 34(11-12):384-97. PubMed ID: 801618
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical studies on the low-dosage norgestrel-ethinylestradiol combination as a long term oral contraception (author's transl)].
    Higashiyama S; Obata T; Kizu S; Nakano Y; Iwasaki T
    Nihon Funin Gakkai Zasshi; 1974 Jan; 19(1):40-53. PubMed ID: 4478810
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive.
    Tankeyoon M; Dusitsin N; Poshyachinda V; Larsson-Cohn U
    Contraception; 1976 Aug; 14(2):199-214. PubMed ID: 949896
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of sequential oral contraceptive pill (Fysioquens) administration on carbohydrate and lipid metabolism.
    Vähäpassi J; Pyörälä T
    Ann Chir Gynaecol; 1979; 68(2):75-81. PubMed ID: 507744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
    Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
    Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptive steroids and carbohydrate metabolism.
    Kulkarni HJ; Gaitonde BB
    Indian J Physiol Pharmacol; 1972 Jan; 16(1):23-9. PubMed ID: 5025961
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles].
    Lévrier M
    Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of ethinyl oestradiol and megestrol acetate on carbohydrate metabolism in rabbits.
    Gaitonde BB; Kulkarni HJ
    Indian J Med Res; 1977 Aug; 66(2):223-35. PubMed ID: 924594
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
    Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of hormonal contraceptives on carbohydrate and lipid metabolism in the rat.
    Schillinger E; Gerhards E
    Biochem Pharmacol; 1973 Aug; 22(15):1835-44. PubMed ID: 4722455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.